Chemically induced pluripotent stem cells biological Artificial Liver for liver failure

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Dec 2025: Trial started, NCT07312864
  2. 31 Dec 2025: Trial registered, NCT07312864

The trials

NCT07312864: Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome

State
Under way
Phase
Phase 1 and Phase 2
People
12 planned
Started
1 Dec 2025
Primary completion
31 Dec 2027
Arms
CiPS-BAL
Results
None posted
  1. 1 Dec 2025: Trial started
  2. 31 Dec 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.